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ABSTRACT 
Hyperpolarized 
3
He ventilation-MRI, anatomical lung MRI, lung clearance index (LCI), low-
dose CT, and spirometry were performed on 19 children (6-16yrs) with clinically stable mild 
CF (FEV1>-1.96), and 10 controls. All controls had normal spirometry, MRI and LCI. 
Ventilation-MRI was the most sensitive method of detecting abnormalities, present in 89% 
CF patients, compared to CT abnormalities in 68%, LCI 47% and conventional MRI 22%. 
Ventilation defects were present in the absence of CT abnormalities and in patients with 
normal physiology, including LCI.  Ventilation MRI is thus feasible in young children, highly 
sensitive and provides addit onal information about lung structure-function relationships.  
 
99 words (Max 100) 
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BACKGROUND 
Lung ventilation heterogeneity due to the obstruction of small airways is an early and 
potentially reversible step in the progression of cystic fibrosis (CF). Individually, multiple 
breath washout (MBW), hyperpolarised (HP) gas ventilation MRI, and conventional 
structural lung imaging by CT, have all been shown to be sensitive to early changes in the 
lungs before spirometry
1-3
. The information they provide is complementary and HP 
ventilation-MRI in particular has the potential to reveal airways obstruction and the 
functional consequences of regional structural changes detected with CT, as well as the 
nature of ventilation heterogeneity that prolongs gas washout in MBW
4
.  The aim of this 
study was to investigate the relative sensitivity of imaging and physiology assessments for 
the detection of early-stage lung disease in children with CF. In addition, we explored what 
insight functional ventilation imaging provides about the nature of ventilation abnormalities 
in the lungs in early CF, and how these correlate with the more clinically scalable 
assessment of ventilation heterogeneity provided by MBW.   
METHODS 
For full technical details, see the online supplement (OLS).  
Nineteen CF children and ten controls were assessed. Subjects attended on a single 
occasion, when clinically stable, and were assessed with SF6 MBW
1
, plethysmography, 
spirometry, HP 
3
He MRI and 
1
H MRI. CF patients also underwent inspiratory and expiratory 
chest CT
5
.  All subjects had FEV1 z-score>-1.96 and were aged between 6-16 years old. To 
test for significant differences between the healthy control and CF patient groups, 2-tailed 
paired tests were performed to reflect the age-matching of data.  Sensitivity was defined as 
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the presence of an abnormal measurement (i.e. not within the normal range for that 
measurement) in the presence of the diagnosis of CF.  This assumes that all patients should 
have some abnormality in at least one measurement, which may not be true in this 
population with very mild clinical expression of CF, and therefore provides a conservative 
estimation of sensitivity of the lung assessments. This study was approved by the National 
Research and Ethics Committee (REC 12/YH/0343) and parents/guardians provided written 
informed consent  
RESULTS 
Full demographic and outcome data are presented in the OLS. CF patients had early-stage 
lung disease, with no significant differences between CF and controls for any lung function 
measures except LCI (Figure 1). In controls, no ventilation or structural abnormalities were 
detected on either 
3
He or 
1
H MRI (see OLS). Both 
3
He MRI quantitative measures were 
however significantly increased in CF patients when compared to controls (Figure 1).  
Ventilation heterogeneity and obstruction seen with ventilation-MRI generally 
corresponded to anatomical abnormalities detected by CT (Figure 4 OLS).  In several 
instances however ventilation defects were present on ventilation-MRI with no 
corresponding features of structural pathology detectable on CT (Figure 2).  
The presence of visible defects on
 
ventilation-MRI had the greatest sensitivity for detecting 
evidence of CF airways disease: nine CF patients (47%) had elevated sitting LCI, when 
compared to 17 (89%) with ventilation-MRI abnormalities. In contrast, structural 
abnormalities were detectable in four patients (22%) with 
1
H MRI and 13 patients (68%) 
with CT. Ventilation-MRI detected abnormalities in four patients with normal CT; LCI was 
abnormal in only two of these.  Two patients with mild variant disease (both R117H-7T 
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heterozygotes) had no abnormality detected by any technique; these were the only CF 
patients where 
3
He MRI was normal. 
A table of correlations is presented in the OLS. LCI and 
3
He MRI metrics showed moderately 
significant correlation and 
3
He MRI %-unventilated lung correlated significantly with CT 
Brody score and CT gas trapping score.  There was no significant correlation between LCI 
and CT scores. 
DISCUSSION 
This is the first study to combine the powerful functional technique of ventilation imaging 
using HP gas MRI with assessments of structural lung disease from CT and the whole lungs 
assessment of ventilation heterogeneity provided by MBW. Although both 
3
He MRI and 
MBW measure aspects of ventilation heterogeneity in the lungs, the detailed spatial 
information provided by ventilation-MRI meant that abnormalities in ventilation distribution 
were visible even when these were insufficient to affect the LCI.  Likewise, ventilation 
defects were visible in some cases in the absence of structural abnormalities on CT (e.g. 
Figure 2), which may be due to the inherent sensitivity of ventilation imaging to small 
airways obstruction that cannot be explicitly resolved on CT. 
These are important findings for our understanding of how CF lung disease develops and 
how we interpret lung function data. In this cohort of CF patients, specifically selected to 
represent those with the mildest airways disease, LCI was abnormal in almost half of all 
subjects (47%), in keeping with prior observations
1, 6
.  Ventilation-MRI however was more 
sensitive than both LCI and CT and detected ventilation defects in all but two patients (89%), 
both of whom had genetic variants that may not be associated with CF lung disease until 
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adulthood. The great advantage of ventilation-MRI is that it offers detailed regional 
information about the nature and distribution of ventilation defects.  Thus in patients with 
early disease we predominantly detected patchy ventilation defects distributed throughout 
the lung, with larger focal defects in areas where there was already evidence of structural 
damage on CT or 
1
H MRI.  In contrast, MBW represents a washout signal integrated over the 
whole lungs, so that mild ventilation heterogeneity can inevitably be masked, and 
differentiation of the signal into regional or anatomical lung compartments is at best 
speculative
7
.  
The 
1
H MRI protocol deployed here was used to determine lung boundaries and was not 
optimised for structural imaging, where new methods like 3D ultra-short echo time imaging 
should offer improvements. Alternative CT scoring systems and protocols also exist that may 
offer additional sensitivity
8
. Finally, we did not perform gadolinium contrast enhanced 
imaging, as we felt this would deter children from participating. Despite possible limitations 
in the 
1
H MRI and CT protocol, it is clear that HP gas ventilation-MRI is a powerful tool for 
detecting early lung changes. The superior sensitivity and detail of information provided by 
ventilation-MRI also offers the prospect that this measurement will allow an earlier or more 
detailed radiation-free appreciation of the response to novel therapies than even LCI
9
. The 
advent of high quality HP gas ventilation-MR imaging using the cheaper and readily available 
129
Xe isotope means that the technology is now much more readily clinically deployed
10
. The 
ventilation-MR images presented here are thus exemplars of what may become routine 
assessments in detecting early disease and treatment effects.  
In conclusion, in this population of CF children with very mild lung disease, we have shown 
that ventilation-MRI is highly sensitive to detecting the consequences of airway disease.  
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Even patients with apparently pristine lungs by all current physiology and imaging standards 
have evidence of ventilation-MRI abnormalities.  HP gas MRI provides detailed regional 
information about disease severity and physiological impairment. 
1115 words (max 1200) 
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Figure captions 
Figure 1 – Comparison of lung physiology and ventilation imaging metrics for healthy 
controls and cystic fibrosis (CF) patients. 
Each point represents a single subject, error bars represent group means and 95% 
confidence interval of the means.  (a) FEV1 z-score and (b) FEV1/FVC z-score derived from 
spirometry. Horizontal dotted line indicates a z-score of zero.  (c) Sitting lung clearance 
index (LCI) and (d) supine LCI from multiple breath washout. Horizontal dotted line 
represents upper limit of normal LCI. (f) Un-ventilated lung volume percentage (UVP) and (f) 
mean coefficient of variation (CV) of ventilation imaging signal, from 
3
He MRI. 
 
Figure 2 - Hyperpolarised gas MRI and CT imaging: examples of discordance in patients with 
cystic fibrosis (CF).  
Each row represents a single unique CF patient, with equivalent slices from hyperpolarised 
gas MRI, CT, and
 1
H MRI in the columns from left to right. In the first subject (a-c), 
3
He MRI 
showed heterogeneous ventilation with widely distributed patchy, semi-ventilated defects 
(a). CT for this slice was normal (expiratory shown in b) and 
1
H MRI (c) was normal 
throughout. In the second CF patient, small, sub-segmental defects were observed 
throughout the lungs with 
3
He MRI (d). CT for this slice was normal (expiratory shown in e) 
but elsewhere showed lingular atelectasis and minimal air-trapping.  
1
H MRI was normal for 
this slice (f) but showed lingular atelectasis elsewhere.  In the final patient, several small 
ventilation defects were seen on 
3
He MRI (g), whilst CT (inspiratory shown in h), 
1
H MRI (i), 
and lung clearance index were all normal. 
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BACKGROUND 
Infection and inflammation develop early in the lungs of patients with cystic fibrosis (CF) and 
typically precede clinical symptoms.
1
 The process appears to start in the peripheral small 
airways (<2mm diameter), which are particularly susceptible to the pathological effects of 
mucus retention and airway wall inflammation.  Over time, a dysregulated inflammatory 
Online Supplement - Full Study Report 
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response to chronic infection leads to progressive remodelling of the small airways and 
bronchiectasis.  Early detection of lung disease is therefore vital in the effective 
management of CF so that interventions can be applied before this process becomes 
irreversible.  A major challenge in clinical practice however is that conventional clinical 
measures of lung function and routine chest radiology are not sensitive enough to identify 
early-stage, predominantly reversible, lung disease.2 
Airway disease in CF does not progress evenly throughout the lungs, and an initial feature is 
uneven distribution of ventilation during tidal breathing. This is a consequence of variability 
in airway resistance and compliance, due to the heterogeneous distribution of obstruction 
and inflammation in the airways. Multiple-breath washout (MBW) of an inert tracer gas 
from the lungs, measured at the mouth during tidal breathing, is influenced by this 
heterogeneity of ventilation distribution.
3
  Quantitative metrics derived from MBW, such as 
lung clearance index (LCI), appear to be particularly sensitive to early CF airways disease4 
and treatment response.
5
  LCI provides a global lung index of overall ventilation 
heterogeneity, but is not regionally specific, i.e. it is not possible to determine whether 
abnormal elevation in LCI is a consequence of multiple small poorly ventilated regions of the 
lungs, or a few larger abnormally ventilated lung regions.
6
  This may explain the variability in 
LCI response to some treatments, such as IV antibiotics given for a CF exacerbation.7   
Hyperpolarized (HP) gas ventilation MRI provides high-resolution images of inhaled tracer 
gas distribution within the lung airspaces, thereby directly imaging the distribution of 
ventilation heterogeneity.  HP ventilation MRI using Helium-3 (3He) has been shown to be 
safe, repeatable and quick to perform in paediatric CF patients, requiring short breath-holds 
to acquire volumetric images of lung ventilation.8-10 Obstructed lung regions appear black, 
and ventilated airspaces have a grey-scale signal intensity that is directly proportional to the 
local gas concentration in the lungs.  The high spatial-resolution images obtained therefore 
provide regional quantitative information on lung ventilation and its heterogeneity. The 
technique has inherent sensitivity to small airways obstruction, is sensitive to early lung 
disease,11 and has been used to demonstrate regional response to therapy in children with 
CF.8 
Individually, MBW and HP gas ventilation MRI, along with conventional structural lung 
imaging by CT, have all been shown to be sensitive to early changes in the lungs before 
spirometry4 11 12. The information they provide is however complementary in terms of 
functional and structural understanding of CF lung disease. HP gas MRI in particular has the 
potential to inform us about the functional consequences of regional structural changes 
detected with CT, and the nature of ventilation heterogeneity that prolongs gas washout in 
MBW.  The aim of this study therefore was to investigate the relative sensitivity of HP gas 
MRI, structural 1H MRI, CT and MBW for the detection of early-stage lung disease in children 
with CF. In addition, we explored what insight functional ventilation imaging provides about 
the nature of ventilation abnormalities in the lungs in early CF, and how these correlate with 
the more clinically scalable assessment of ventilation heterogeneity provided by MBW.   
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METHODS 
This was a cross-sectional observational study of patients with mild cystic fibrosis (CF) and 
healthy controls. All subjects attended on a single occasion, whilst clinically stable, and 
underwent a series of lung function and radiological assessments during the same visit. 
Visits took place between February 2013 – August 2014. 
This study was approved by the Leeds East Research and Ethics Committee. 
Parents/guardians signed informed consent and paediatric subjects provided assent. 
 
Inclusion criteria for CF patients: 
 6 years < age < 16 years  
 Diagnosis of CF confirmed by a characteristic phenotype in conjunction with sweat 
test and/or genotyping.  
 FEV1 z-score > -1·96 
 Clinically stable and free of symptoms of respiratory exacerbation 
 
Exclusion criteria for CF patients: 
 Any contraindication to MRI 
CF patients were reviewed on the day of the study procedures by a clinician to confirm that 
they were clinically stable. 
 
Inclusion criteria for healthy volunteers: 
 6 years < age < 16 years 
 
Exclusion criteria for healthy volunteers: 
 History of respiratory illness, prematurity, or previous assisted lung ventilation  
 Any contraindication to MRI 
 
Sample size 
The original target sample size was 20 CF patients, and 10 healthy controls. This size was 
selected based on the known sensitivities of both the 3He HP gas MRI technique and MBW. 
In previous studies in paediatric CF patients of the repeatability of 
3
He-MRI lung ventilation 
volume, we observed a standard deviation of 5% between scans8. Thus 15 subjects were 
sufficient to detect a difference of one SD in lung volume when compared to healthy 
controls with 90% power at the 5% significance level. We therefore aimed to recruit 20 
patients to allow some reserve in case of technical difficulties. This number was also felt to 
be realistically achievable, given the small size of the target population (CF children with 
well-preserved spirometry) and the intensive nature of the study visit. Healthy controls 
were recruited 1:2 compared to patients with age within +/-2 years. 
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Study protocol 
Subjects completed a series of non-invasive physiological and radiological assessments, see 
Figure 1. All subjects underwent physiology assessments together in a single session in the 
following order: multiple breath washout (MBW) sitting followed by supine; 
plethysmography; spirometry. The order of lung function testing was designed to ensure 
that dynamic spirometry manoeuvres did not impact on the MBW, as performing dynamic 
spirometry manoeuvres immediately or shortly prior to MBW may alter LCI.13 
Hyperpolarised (HP) 
3
He and 
1
H MRI were performed on the same day, within 3 hours of the 
physiology tests, though the order of these was not fixed. Children with CF, but not healthy 
controls, also underwent a chest CT scan. Data on microbiology, genotyping and sweat 
chloride were retrieved from the clinical record. 
 
 
 
Figure 1: Summary of study flow and assessments.  
MRI: Magnetic Resonance Imaging. CT: Computed tomography 
 
 
Multiple Breath Washout 
Multiple breath washout was performed as previously described, using a modified 
InnocorTM gas analyzer and 0.2 % sulfur hexafluoride (SF6) as the tracer gas.
14 Unlike the 
earlier study, a faster-responding system was used, with a gas analyser response time of 
<120ms. For this reason no speeding correction was applied to the flow gas delay. Signals 
were aligned using a mechanical solenoid-activated gas pulse, rather than performing the 
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on board flow-gas delay measurement. This has previously been shown to have superior 
accuracy and repeatability.15 
 
Multiple breath washout tests were performed both seated and supine, with the subjects 
suitably distracted by watching television. A nose clip was applied and tidal breathing 
established whilst the subject breathed through a mouthpiece attached to a low dead-space 
filter (air safety medical, UK) and flow meter (Hans Rudolph paediatric pneumotach 0 – 160 
L/min flow range, Kansas, USA). 
 
During the wash-in, the subject inspired 0.2% SF6 in air from a flow-past circuit attached to 
the end of the mouthpiece and flow meter apparatus.  Wash-in gas was supplied from a 
compressed gas cylinder (BOC, Guildford, UK), with the gas flow rate adjusted to ensure that 
rebreathing did not occur. The wash-in phase was continued until inspiratory and expiratory 
SF6 concentrations differed by less than 0.004% (absolute difference in SF6 concentration). 
Once wash-in was complete, the flow-past circuit was manually detached during expiration, 
and the washout commenced.  
 
During the washout the subject breathed room air until the end tidal SF6 concentration had 
fallen to less than 0.005% (1/40th of the SF6 concentration at the end of wash-in). Each 
subject completed a minimum of six washouts. Sitting washouts were performed first, 
followed by supine washouts conducted whilst the patient lay horizontal on an examination 
couch, with the MBW mouthpiece supported in the correct position above them.  Further 
wash-outs were performed if any suspected measurement errors occurred during testing, to 
ensure a total of three good quality trials were available for analysis in each postural 
position. 
 
Functional residual capacity (FRC) was calculated from the total volume of expired tracer 
gas, and end tidal tracer gas concentrations at start and end of the washout,3 and adjusted 
for BTPS.  
 
Lung Clearance Index (LCI) is defined as the cumulative expired volume required to reduce 
the end tidal tracer gas to 1/40th of the starting concentration, divided by the FRC. LCI is 
quoted as the mean of at least two reproducible repeats from washouts of satisfactory 
quality. As an additional quality control measure, washouts whose FRC differed by more 
than 10% from both of the other two repeats were excluded from analysis.  
 
 
Plethysmography 
Body plethysmography and spirometry were performed on a CareFusion Jaeger ‘PFT Pro’, 
using SentrySuite software version 2.10 (Basingstoke, UK). All testing was performed to 
ATS/ERS recommended standards.13 16 17  Flow was measured using a Lilly-type heated 
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screen pneumotachograph and volume measurements obtained using a software-based 
integrator.  Calibration of the system was performed prior to each subject in accordance 
with manufacturer’s instructions and in line with ATS/ERS criteria.13 16 
 
For spirometry and the plethysmography pneumotach, a three litre air syringe was 
repeatedly discharged at a steady flow (approximately 6lps) and then verified for linearity 
over a range of flows. Body plethysmography was performed with an 830 litre constant-
volume body plethysmograph (CareFusion, Basingstoke, UK) and was calibrated using an 
automated system for the air leak time decay and volume displacement. 
 
The subject was seated in the plethysmograph in an upright position with a nose clip in 
place and lips tightly sealed around the mouthpiece.  This was connected to a single use 
bacterial filter attached to a pneumotachograph located within the plethysmograph.  
Following a short period of tidal breathing the airway was then occluded for three seconds 
at FRC by a shutter attached to the distal side of the pneumotachograph and the patient 
instructed to make continued respiratory efforts against the occlusion. Thoracic gas volume 
(TGV) was calculated from the change in the plethysmograph pressure that occurred during 
the respiratory efforts against the occlusion. On releasing the occlusion the subject was then 
instructed to perform slow, maximal inhalation followed by a maximal exhalation to RV.  TLC 
and RV were determined from the measurements of TGV and slow vital capacity. 
 
Spirometry 
Repeated spirometry efforts were performed until 3 acceptable maximal manoeuvres were 
obtained.  Traces showing evidence of incomplete expiration, cough, air leak or glottic 
closure, were rejected.  Acceptable repeatability was obtained when the difference 
between the largest and next largest manoeuvres was ≤ 100 ml or 5% depending on which 
was the larger value.  
 
The recorded result for FEV1 and FVC was the highest achieved across all technically correct 
efforts, with the ratio calculated from this.  Forced expiratory volume in 1 second (FEV1), 
FEV1/FVC (forced vital capacity) and reduction in forced expiratory flow at 25-75% of the 
FVC (FEF25-75) were expressed as z-scores as described by Quanjer et al.
18 
 
MRI 
Subjects were scanned using a 1·5T whole body MRI system (GE HDx, Milwaukee, WI) 
equipped for hyperpolarised 3He imaging.  3He was polarised on site to around 25% using 
rubidium spin-exchange apparatus19 (GE Healthcare, Amersham, UK) under a regulatory 
approved license from the UK MHRA.   
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3
He Ventilation MRI 
Subjects were positioned in a 3He quadrature transmit-receive vest coil (Medical Advances, 
USA or Clinical MR Solutions, USA depending on size).  Hyperpolarized 3He dose was 
determined empirically according to the subject's predicted functional residual capacity 
(FRC).
20
 A gas mixture of equal parts 
3
He and N2 was inhaled from functional residual 
capacity (FRC) and ventilation images were acquired during breath-hold.  Breathing control 
was strictly implemented by thorough training and instruction from a lung physiologist.  The 
specified volume of hyperpolarised gas was delivered to the subject from a Tedlar bag of 
known volume and subjects inhaled from FRC. A nose clip was used to best ensure that all 
delivered gas was inhaled into the lungs.  A 2D coronal spoiled gradient echo sequence was 
used for imaging with parameters: full lung coverage, θ=8⁰, field of view = 30 - 40cm 
depending on subj ct size, in-plane matrix = 128 x 102, slice thickness = 10 mm, TE / TR = 1.1 
/ 3.6 ms, bandwidth = 63 kHz and sequential phase encode ordering.  With the subject in the 
same position within the 3He coil, 
1
H images of the same imaging volume were acquired 
using the scanner body coil after inhalation from FRC of an equivalent volume of air to the 
gas volume inhaled for 3He MRI.  A 2D coronal steady state free precession sequence was 
used for imaging with θ = 50⁰, field of view = 30 - 40cm depending on subject size, in-plane 
matrix = 256 x 204, slice thickness = 10 mm, TE / TR = 0.9 / 2.9ms and bandwidth = 250kHz. 
 
3He ventilation images were evaluated for the presence of any abnormal ventilation 
heterogeneity by a radiologist with six years' experience of clinical paediatric chest imaging 
(DH), blinded to other results.  1H body-coil images were registered to the 3He ventilation 
images to correct for any changes in position or lung inflation between the helium and 
proton image acquisitions.  Lung un-ventilated volume percentage (UVP) was calculated by 
manual segmentation of the 3He images overlaid on the registered 1H images.  A signal 
threshold was applied to delineate ventilated and un-ventilated voxels.  The whole lung 
ventilated volume (VV) was calculated by summing all ventilated voxels and multiplying by 
the voxel volume.  An outline was manually drawn to estimate total lung volume (TLV), and 
the whole lung un-ventilated volume percentage 21 was calculat d as UVP = (1 - VV/TLV) x 
100.  To measure ventilation heterogeneity, maps of coefficient of variation (CV) were 
calculated as standard deviation / mean for an in-plane kernel of 3 x 3 pixels. This was 
calculated for each voxel of the lung and the outcome measure mean CV is the whole lung 
mean of these coefficient of variation values.  If image signal to noise (SNR) ratio was less 
than 20 no CV analysis was performed as low SNR results in increased CV independent of 
ventilation heterogeneity.  
 
1
H Anatomical MRI 
Subjects were repositioned into a 
1
H 8-element chest receiver array.  A volume of air equal 
to the total gas volume inhaled for 3He MRI was inhaled from FRC, and anatomical 1H 
images were acquired during breath-hold.  A 2D coronal steady state free precession 
sequence was used for imaging with parameters: full lung coverage, θ = 50⁰, field of view = 
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30 - 40cm depending on subject size, in-plane matrix = 256 x 204, slice thickness = 10 mm, 
TE / TR =0.9 / 2.9 ms and bandwidth = 250 kHz. This steady state sequence was previously 
shown to be sensitive to mucus, effusion and other early structural changes in CF lungs.22 
 
The images were evaluated by an experienced paediatric chest radiologist (DH) for the 
presence of any morphologic abnormalities including bronchial wall thickening, mucus 
plugging, bronchiectasis, consolidation and atelectasis,23 blinded to other results. 
 
The MRI scanner room time for the 
1
H and 
3
He imaging reported in this study - namely fast 
anatomical MRI and a HP 3He breath-hold ventilation scan - takes between 10-15 minutes in 
total, comparable to the imaging time of CT.  
 
Computed Tomography (CT) 
Low dose inspiratory and ultra-low dose expiratory non-contrast volume CT images were 
acquired from patients only, following the protocol of Loeve and colleagues.24  All 
participants were scanned on a GE Lightspeed VCT 64 CT scanner (GE Healthcare, 
Milwaukee, WI, USA) in the supine position.  Similar breathing instructions were given to 
each child.  Tube voltage was 80 kV for children weighing less than 35 kg and 100 kV for 
those weighing 35 kg or more.   End-inspiratory scans were performed with a modulating 
tube current, limited to a maximum of 150 mA (auto mAs, GE) but end-expiratory scans 
were performed at a fixed current of 25 mA, and as a result were lower dose.  A gantry 
rotation time of 0.6 s was used with a pitch of 1.375 and 5 mm collimation (retrospectively 
reconstructed to 2.5 mm slice thickness with a 1.25 mm increment).  
 
Volume Control 
In our experience, we have found that training the patient with the inspiratory and 
expiratory manoeuvres used here, before entering the CT and MR scanners, is as effective 
as spirometric control and we have previously validated this with pneumotachograph 
experiments in the scanner.  
 
CT images were scored according to the system proposed by Brody and colleagues,
25
 for 
bronchiectasis, mucus plugging, peri-bronchial thickening, parenchymal opacities and air 
trapping, by two radiologists, each with six years' experience of chest imaging (DH and AJS), 
blinded to other results.  Images were scored independently and then any differences 
resolved by consensus.  Intra-class correlation and Bland-Altman analysis was used to assess 
inter-observer variability between the two radiologists before and after consensus.  The 
reported CT Brody scores are the mean of the scores from the two observers.  The CT gas 
trapping score reported is a component of the Brody score,
25
 which was extracted for 
correlation analysis with other measures. 
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Statistical Analysis 
Statistical analysis was performed using GraphPad Prism (San Diego, USA).  Data were tested 
for normality using the D’Agostino and Pearson omnibus normality test and for difference 
between variances of the healthy control and CF patient groups. To test quantitative metrics 
for significant differences between the healthy control and CF patient groups, if data were 
normal with equal variances a 2-tailed t-test was performed, if data were normal with 
unequal variances a 2-tailed t-test with Welch's correction was performed, and if data were 
not normal a 2-tailed Wilcoxon signed rank test was performed.  Paired tests were used to 
reflect the age-matching of data. Pearson's correlations were carried out for normal data 
and Spearman's correlations were performed where data were not normal.  
Receiver-operator characteristic (ROC) curve analysis was performed using GraphPad Prism 
to compare sensitivity and specificity of different lung function assessments. Sensitivity was 
defined as the presence of an abnormal measurement (i.e. not within the normal range for 
that measurement) in the presence of the diagnosis of CF. This assumes that all patients 
should have some abnormality in at least one measurement, which may not be true in this 
population with very mild clinical expression of CF, and therefore provides a conservative 
estimation of sensitivity of the lung assessments. Where confidence intervals for ROC 
analysis exceeded 1 (or 100%) these have been rounded to 1.  
Significance level was set at p=0.05. 
 
RESULTS 
Recruitment 
Nineteen patients with CF and ten age-matched healthy controls were assessed. Healthy 
controls were recruited from friends and families of members of staff involved in the study, 
and one healthy control was a sibling of a CF patient taking part in the study. 150 patients 
were in care of the SCH Pediatric CF clinic at the time of the study. 43 of these fulfilled the 
inclusion criteria (normal FEV1, no respiratory exacerbation). 23 of these patients were 
approached to participate, 1 patient did not want to take part as they did not want to miss 
school, 1 mother thought it might upset her 6 year old so did not want to take part, and 1 
patient wanted to take part but we were unable to contact the family. 1 patient dropped 
out following the CT scan due to emigration of the family. 1H MRI was not performed on one 
of the remaining 19 CF patients, and plethysmography could not be performed adequately 
in one additional CF patient and one control. The study response rate was therefore 87 % 
and study completion rate was 95%.  
 
Lung function outcomes 
Demographic, lung function, and quantitative imaging data are presented in Table 1.   
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There were no significant differences between controls and CF patients for age, weight, 
height or body mass index (BMI). CF patients had early-stage lung disease and all patients 
had FEV1 and FEV1/FVC z-scores greater than the lower limit of normal. There were no 
significant differences between groups for FEV1 z-score (Figure 2a), FEV1/FVC z score (Figure 
2b), FEF25-75 z-score or RV/TLC. Both sitting and supine LCI were significantly elevated in the 
CF patient group when compared to healthy controls (Figure 2c-d) (sitting LCI; mean 
difference (md) = 0.82, confidence interval (CI) 0.06 – 1.58, p=0.037), though overall CF 
patient group mean LCI sitting was below the upper limit of normal14. 
  
Table 1 – Comparison of demographic, lung function and imaging data in healthy controls 
and subjects with cystic fibrosis. 
Values given as mean (standard deviation) except for CT Brody score and CT hyperinflation 
score (non-parametric data), which are given as median (range). CT was not performed in 
healthy controls. P-values represent paired t-tests or Wilcoxon signed rank tests of CF 
subjects compared to healthy controls. 
 
 
 
 
 
 
 
Measurement Healthy Controls CF Patients p-value 
Male : Female 4 : 6 10 : 9  
Age (years) 11.3 (2.8) 10.9 (2.5) 0.461 
Height z-score 0.830 (0.910) 0.005 (0.951) 0.351 
Weight z-score 0.707 (1.222) 0.256 (0.699) 0.625 
Body Mass Index z-score 0.265 (1.195) 0.324 (0.864) 0.857 
FEV1 z-score 0.001 (1.022) -0.302 (0.851) 0.297 
FEV1/FVC z-score 0.002 (0.749) -0.594 (0.686) 0.098 
FEF25-75 z-score -0.07 (1.05) -0.68 (0.78) 0.447 
RV/TLC (%) 25.0 (5.9) 26.6 (4.5) 0.298 
LCI sitting 6.4 (0.5) 7.3 (0.9) 0.037 
LCI supine 6.6 (0.4) 7.7 (1.3) 0.027 
3
He MRI UVP (%) 1.53 (0.24) 4.34 (2.00) 0.004 
3
He MRI mean CV (%) 11.97 (0.87) 13.81 (1.59) 0.012 
CT Brody score - 12.5 (0.0 - 56.3)  
CT hyperinflation score - 3.0 (0.0 - 15.0)  
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Figure 2 – Comparison of lung physiology and ventilation imaging metrics for healthy 
controls and cystic fibrosis (CF) patients. 
Each point represents a single subject, error bars represent group means and 95% 
confidence intervals of the mean.  (a) FEV1 z-score and (b) FEV1/FVC z-score derived from 
spirometry. Horizontal dotted line indicates a z-score of zero.  (c) Sitting lung clearance 
index (LCI) and (d) supine LCI from multiple breath washout. Horizontal dotted line 
represents upper limit of normal for sitting LCI. (f) Un-ventilated lung volume percentage 
(UVP) and (f) mean coefficient of variation (CV) of ventilation imaging signal, from 3He MRI. 
This is the same as Figure 1 in the main letter. 
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Imaging outcomes 
In healthy controls, no ventilation or structural abnormalities were detected on either 
3
He 
or 1H MRI, see Figure 3 for example images.   
3
He UVP and ventilation heterogeneity measured by mean CV were both significantly 
increased in the CF patient group when compared to healthy controls (md = 2.77, CI 1.15 – 
4.39, p=0.004 and md = 1.62, CI 0.46 – 2.78, p=0.012 respectively) (Table 1, Figure 2e-f).  
Ventilation heterogeneity and obstruction seen with 
3
He MRI generally corresponded to 
anatomical abnormalities observed by CT, such as mucus plugging, air trapping, 
bronchiectasis and atelectasis (Figure 4).  However, in several instances regional ventilation 
heterogeneity was present on 3He MRI with no obvious features of structural pathology 
visible on CT (Figure 5). 
  
 
 
Figure 3 – Lung ventilation hyperpolarised gas MRI and 
1
H MRI in healthy controls 
(a) 3He MRI of a representative healthy control subject (age 10 years) showing 
homogeneous ventilation extending fully to the lung boundaries. The equivalent coronal 
slice of the 1H MRI is shown in 3(b). 
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Figure 4 – Hyperpolarised gas MRI and CT imaging: examples of correspondence in 
patients with cystic fibrosis (CF). 
Each row represents a single unique CF patient, with equivalent slices from hyperpolarised 
(HP) gas MRI, CT, and
 1
H MRI in the columns from left to right. (a-c) are scans from a CF 
patient with arrows indicating segmental collapse visualised by all three imaging modalities.  
3
He ventilation defects in the upper left lung (a) correspond to atelectasis and nodular 
change on inspiratory CT (b).  
In (d-f) arrows indicate lingular atelectasis, in a CF patient with normal lung clearance index. 
The obstruction seen with 3He MRI (d) extends more proximally than the atelectasis seen on 
inspiratory CT (e) and 1H MRI (f).  
In the final subject, 
3
He MRI ventilation heterogeneity (g) and air trapping on expiratory CT 
(h) were visible throughout the lungs, especially in the upper lobes.  No abnormalities were 
detected with 1H MRI (i). 
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Figure 5 - Hyperpolarised gas MRI and CT imaging: examples of discordance in patients 
with cystic fibrosis (CF).  
Each row represents a single unique CF patient, with equivalent slices from hyperpolarised 
gas MRI, CT, and
 1
H MRI in the columns from left to right. In the first subject (a-c), 
3
He MRI 
showed heterogeneous ventilation with widely distributed patchy, semi-ventilated defects 
(a). CT for this slice was normal (expiratory shown in b) and 1H MRI (c) was normal 
throughout. In the second CF patient, small, sub-segmental defects were observed 
throughout the lungs with 3He MRI (d). CT for this slice was normal (expiratory shown in e) 
but elsewhere showed lingular atelectasis and minimal air-trapping.  1H MRI was normal for 
this slice (f) but showed lingular atelectasis elsewhere.  In the final patient, several small 
ventilation defects were seen on 
3
He MRI (g), whilst CT (inspiratory shown) (h), 
1
H MRI (i), 
and lung clearance index were all normal. 
This figure is also presented as Figure 2 in the main letter. 
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Comparison of Different Methods   
The presence of visible defects on 3He MRI had the greatest sensitivity for detecting 
evidence of CF airways disease: nine CF patients (47%) had elevated sitting LCI, compared to 
17 CF patients (89%) with ventilation abnormalities detected by 3He MRI.  Receiver 
operating characteristic (ROC) analysis showed 
3
He MRI metrics to be more accurate than 
LCI or spirometry, with area under the curve values of 0.94 (CI 0.84 – 1.0) for 3He MRI UVP, 
0.87 (CI 0.73 – 1.0) for 
3
He MRI mean CV, 0.79 (CI 0.62 – 0.95) for sitting LCI and 0.59 (CI 
0.37 – 0.82) for FEV1 z-score (Figure 6 and Table 2).  
 
 
 
Figure 6 - Receiver Operating Characteristic Curves for FEV1, sitting LCI and 
3
He MRI 
metrics 
Receiver operating characteristic (ROC) curves for FEV1 z-score (Area Under Curve (AUC) = 
0.59 (CI 0.37 – 0.82), purple), sitting LCI (AUC = 0.79 (CI 0.62 – 0.95), p < 0·05, pink), 
3
He MRI 
mean CV (AUC = 0.87 (CI 0.73 – 1.01), p < 0·01, black) and 3He MRI UVP (AUC = 0.94 (CI 0.84 
– 1.04), p<0·001, blue).  See also Table 2.  
 
 
 
Metric Area Under Curve 95% Confidence Interval p-value 
FEV1 z-score 0.59 0.37 - 0.82 0.4089 
FEV1/FVC z-score 0.70 0.49 - 0.92 0.0851 
Sitting LCI 0.79 0.62 - 0.95 0.0116 
Supine LCI 0.82 0.65 - 0.98 0.0059 
3
He MRI UVP (%) 0.94 0.84 - 1.0 0.0001 
3
He MRI mean CV (%) 0.87 0.73 - 1.0 0.0019 
 
Table 2 - ROC analysis for spirometry, LCI and 
3
He MRI 








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Structural abnormalities were detectable in four patients (22%) with 1H MRI when 
compared to 13 patients (68%) with CT (Table 3).  1H MRI showed lingular atelectasis in four 
patients, segmental lobar collapse in one patient and severe bronchiectasis in one patient.  
However the 
1
H MRI performed here was not sensitive to more subtle changes detected by 
3He MRI and CT in this group of patients with early CF lung disease.  In contrast, only two CF 
patients (11%) had FEV1 z-scores below the 5th percentile (-1.87 and -1.69 respectively), and 
one patient had airflow obstruction as defined by FEV1/FVC z-score <-1.64.  
3He MRI 
detected abnormality in four patients when CT was normal.  LCI was abnormal in only two of 
these four patients.  Two patients with mild variant disease (both Phe508del and R117H 
heterozygotes with 7T poly-T status and sweat chloride of 28 and 68mmol/L respectively) 
had no abnormality detected by any technique; these were the only two patients where 
3
He 
MRI was normal. 
 
 
 
 
FEV1 z-score 
<-1.96 
LCI > 7.4 
Visible 
Abnormality 
on 
3
He MRI 
Visible 
Abnormality 
on basic 
1
H 
MRI 
Abnormality on CT 
(Brody score>6) 
Cystic fibrosis 
(N=19) 
0 (0%) 9 (47%) 17 (89%) 4 (22%)* 13 (68%) 
Controls 
(N=10) 
0 (0%) 0 (0%) 0 (0%) 0 (0%) N/A 
 
Table 3 – Comparison of sensitivity of lung function and imaging modalities to detection of 
lung abnormalities in children with cystic fibrosis.  
Data are presented as number of subjects where lung abnormalities were detected 
(percentage of total number of patients or controls respectively).   
*Total number of patients who underwent 1H MRI was 18. 
 
 
Correlation between Different Measures 
3
He MRI UVP (r=0.61,p=0.008), 
3
He MRI mean CV (r=0.52, p=0.026), LCI (r=0.47, p=0.047), 
and CT gas trapping score (0.48, p=0.045) all showed moderately significant correlations 
with RV/TLC, but no significant correlation with other pulmonary function test results.  LCI 
and 3He MRI metrics showed moderately significant correlation (LCI sitting and 3He MRI UVP 
r=0.55, p=0.015; LCI supine and 3He MRI mean CV r=0.48, p=0.038).  3He MRI UVP correlated 
significantly with CT Brody score (r=0.47, p=0.04) and CT gas trapping score (r=0.58, 
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p=0.009).  There was no significant correlation between LCI and CT scores.  The observed 
correlations are summarised in Table 4. 
 
 
 
 
Table 4 - Significant correlations between lung function, LCI, 3He MRI and CT Quantitative 
Results 
Correlations were calculated using Pearson's correlation where both sets of data were 
normally distributed and Spearman's correlation where one or more datasets were not 
normally distributed. Only correlations where the p value was less than 0.05 are shown. No 
attempt has been made to adjust for multiple correlations in this summary. 
 
 
  
Metric 1 Metric 2 p-value R value 
FEV1/FVC z-score FEF25-75 z-score <0.0001 0.78 
LCI sitting LCI supine <0.0001 0.73 
3
He MRI UVP RV/TLC 0.008 0.61 
3
He MRI UVP CT gas trapping 0.009 0.58 
3
He MRI UVP 
3
He mean CV 0.009 0.58 
LCI sitting 
3
He MRI UVP 0.015 0.55 
FEV1 z-score FEF25-75 z-score 0.019 0.55 
3
He MRI mean CV RV/TLC 0.026 0.52 
FEV1 z-score RV/TLC 0.026 -0.52 
LCI supine 
3
He mean CV 0.038 0.48 
3
He MRI UVP CT Brody score 0.044 0.47 
CT gas trapping RV/TLC 0.045 0.48 
LCI sitting RV/TLC 0.046 0.47 
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Three-dimensional imaging of ventilation distribution 
Three-dimensional images of lung ventilation can be generated from the two-dimensional 
slices shown in Figures 3-5. These allow an overview of ventilation distribution in the lungs, 
and by extension a view of disease distribution. A three-dimensional image rendered from 
the scans performed for this study is shown in Figure 7. Higher resolution is possible with 
alternative protocols. 
 
 
 
Figure 7 – Three-dimensional rendering of ventilation distribution in a child with cystic 
fibrosis 
Image was generated from 10mm slices performed as part of protocol described in the 
methods. 
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Computed Tomography scoring 
Intra-class correlation between the CT scores of the two radiologists was r=0.76, p<0.01 
before consensus and r=0.93, p<0.01 after consensus was achieved, demonstrating a high 
level of agreement. Agreement between scorers is illustrated in Figure 8. A mean difference 
between scorers of -1.9 was found, with standard deviation of 4.4. This is similar to, if not 
better than, previous reports of Bland-Altman analysis between CT raters
26
. As previously 
reported, agreement tends to be least good in those with the lowest scores
26 27
. 
 
 
 
Figure  8.  Bland-Altman plot comparing Brody scores of both radiologists after consensus. 
A mean difference of -1.9 with a standard deviation of 4.4 was found. The dashed line 
represents the mean difference and dotted lines 95% confidence intervals.  
 
 
 
 
DISCUSSION 
This is the first study to combine the powerful functional technique of ventilation imaging 
using HP gas MRI with assessments of structural lung disease from CT and the more scalable 
assessment of ventilation heterogeneity provided by MBW. Although both 3He MRI and 
MBW measure aspects of ventilation heterogeneity in the lungs, the detailed spatial 
information provided by ventilation-MRI meant that abnormalities in ventilation distribution 
were visible even when these were insufficient to affect the LCI.  Likewise, ventilation 
defects were visible in some cases in the absence of structural abnormalities on CT (e.g. 
Figure 5), which may be due to the inherent sensitivity of ventilation imaging to small 
airways obstruction that cannot be explicitly resolved on CT. 
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These are important findings for our understanding of how CF lung disease develops and 
how we interpret lung function data. In this cohort of CF patients, specifically selected to 
represent those with the mildest airways disease, LCI was abnormal in almost half of all 
subjects (47%), in keeping with prior observations1 5.  Ventilation-MRI however was more 
sensitive than both LCI and CT and detected ventilation defects in all but two patients (89%), 
both of whom had genetic variants that may not be associated with CF lung disease until 
adulthood. The great advantage of ventilation-MRI is that it offers detailed regional 
information about the nature and distribution of ventilation defects.  Thus in patients with 
early disease we predominantly detected patchy ventilation defects distributed throughout 
the lung, with larger focal defects in areas where there was already evidence of structural 
damage on CT or 1H MRI.  In contrast, MBW follows an averaged washout signal from the 
lungs, so that mild ventilation heterogeneity is inevitably masked, and differentiation of the 
signal into regional or anatomical lung compartments is at best speculative6.  
The 1H MRI protocol deployed here was used to determine lung boundaries and was not 
optimised for structural imaging. Alternative CT scoring systems and protocols also exist that 
may offer additional sensitivity7. Finally, we did not perform gadolinium contrast enhanced 
imaging, as we felt this would deter children from participating. Even given these limitations 
however, it is clear that ventilation-MRI is a powerful tool for detecting early lung changes. 
The superior sensitivity and detail of information provided by ventilation-MRI also offers the 
prospect that this measurement will allow an earlier or more detailed radiation-free 
appreciation of the response to novel therapies than even LCI.8 The advent of high quality 
HP gas ventilation-MR imaging using the cheaper and readily available 129Xe isotope means 
that the technology is now much more readily clinically deployed.9 The ventilation-MR 
images presented here are thus exemplars of what may become routine assessments in 
detecting early disease and treatment effects.  
In conclusion, in this population of CF children with very mild lung disease, we have shown 
that ventilation-MRI is highly sensitive to detecting the consequences of airway disease.  
Even patients with apparently pristine lungs by all current physiology and imaging standards 
have evidence of ventilation-MRI abnormalities.  HP gas MRI provides detailed regional 
information about disease severity and physiological impairment. 
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